The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation
Open accessAbstract
Significance: A hyperinflammatory syndrome reminiscent of toxic shock syndrome (TSS) is observed in severe COVID-19 patients, including children with Multisystem Inflammatory Syndrome in Children (MIS-C). TSS is typically caused by pathogenic superantigens stimulating excessive activation of the adaptive immune system. We show that SARS-CoV-2 spike contains sequence and structure motifs highly similar to those of a bacterial superantigen and may directly bind T cell receptors. We further report a skewed T cell receptor repertoire in COVID-19 patients with severe hyperinflammation, in support of such a superantigenic effect. Notably, the superantigen-like motif is not present in other SARS family coronaviruses, which may explain the unique potential for SARS-CoV-2 to cause both MIS-C and the cytokine storm observed in adult COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
SWISS-MODEL: homology modelling of protein structures and complexes
Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky427 · Cited by 13,067
CHARMM‐GUI: A web‐based graphical user interface for CHARMM
Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008) · Journal of Computational Chemistry · doi:10.1002/jcc.20945 · Cited by 9,284
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
The ClusPro web server for protein–protein docking
Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017) · Nature Protocols · doi:10.1038/nprot.2016.169 · Cited by 3,310
An inflammatory cytokine signature predicts COVID-19 severity and survival
Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605
Hyperinflammatory shock in children during COVID-19 pandemic
Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N., & Theocharis, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31094-1 · Cited by 2,494
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., Bonanomi, E., & D'Antiga, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31103-x · Cited by 2,380
Whittaker, E., Bamford, A., Kenny, J., Kaforou, M., Jones, C. E., Shah, P., Ramnarayan, P., Fraisse, A., Miller, O., Davies, P., et al. (2020) · JAMA · doi:10.1001/jama.2020.10369 · Cited by 1,994
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2349-y · Cited by 1,885
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Pinto, D., Park, Y.-J., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., De Marco, A., et al. (2020) · doi:10.1101/2020.04.07.023903 · Cited by 1,752
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667
Self-citationImmunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C. D., So, R. T. Y., Lv, H., Mok, C. K. P., & Wilson, I. A. (2020) · Science · doi:10.1126/science.abb7269 · Cited by 1,463
Xu, Y., Li, X., Zhu, B., Liang, H., Fang, C., Gong, Y., Guo, Q., Sun, X., Zhao, D., Shen, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0817-4 · Cited by 1,415
PRODIGY: a web server for predicting the binding affinity of protein–protein complexes
Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M., & Vangone, A. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw514 · Cited by 1,413
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., et al. (2020) · Science · doi:10.1126/science.abc6952 · Cited by 1,385
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Shi, R., Shan, C., Duan, X., Chen, Z., Liu, P., Song, J., Song, T., Bi, X., Han, C., Wu, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2381-y · Cited by 1,286
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Hansen, J., Baum, A., Pascal, K. E., Russo, V., Giordano, S., Wloga, E., Fulton, B. O., Yan, Y., Koon, K., Patel, K., et al. (2020) · Science · doi:10.1126/science.abd0827 · Cited by 1,210
Cao, Y., Su, B., Guo, X., Sun, W., Deng, Y., Bao, L., Zhu, Q., Zhang, X., Zheng, Y., Geng, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.025 · Cited by 1,188
Belhadjer, Z., Méot, M., Bajolle, F., Khraiche, D., Legendre, A., Abakka, S., Auriau, J., Grimaud, M., Oualha, M., Beghetti, M., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048360 · Cited by 1,129
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120 · cited 6×
“A total of 142 such crossreactive epitopes were identified upon screening 474 peptides in the SARS-CoV-2 proteome (24).”
BackgroundResultInfluentialPotently neutralizing and protective human antibodies against SARS-CoV-2
Zost, S. J., Gilchuk, P., Case, J. B., Binshtein, E., Chen, R. E., Nkolola, J. P., Schäfer, A., Reidy, J. X., Trivette, A., Nargi, R. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2548-6 · Cited by 1,041
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.
Choi, Y. W., Kotzin, B., Herron, L., Callahan, J., Marrack, P., & Kappler, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8941 · Cited by 955
Song, W., Gui, M., Wang, X., & Xiang, Y. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007236 · Cited by 834
Peitsch, M. C. (1995) · Nature Biotechnology · doi:10.1038/nbt0795-658 · Cited by 817
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2
Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., & Thompson, R. F. (2020) · Journal of Virology · doi:10.1128/jvi.00510-20 · Cited by 561
Weisberg, S. P., Connors, T. J., Zhu, Y., Baldwin, M. R., Lin, W.-H., Wontakal, S., Szabo, P. A., Wells, S. B., Dogra, P., Gray, J., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00826-9 · Cited by 548
T Cell Responses to Whole SARS Coronavirus in Humans
Li, C. K.-F., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 497
The bacterial superantigen and superantigen‐like proteins
Fraser, J. D., & Proft, T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00681.x · Cited by 495
Schultheiß, C., Paschold, L., Simnica, D., Mohme, M., Willscher, E., von Wenserski, L., Scholz, R., Wieters, I., Dahlke, C., Tolosa, E., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.024 · Cited by 333
Self-citationTHE STRUCTURAL BASIS OF T CELL ACTIVATION BY SUPERANTIGENS
Li, H., Llera, A. S., Malchiodi, E. L., & Mariuzza, R. A. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.435 · Cited by 324
Antibody-Dependent Enhancement of Virus Infection and Disease
Tirado, S. M. C., & Yoon, K.-J. (2003) · Viral Immunology · doi:10.1089/088282403763635465 · Cited by 313
The protein structure prediction problem could be solved using the current PDB library
Zhang, Y., & Skolnick, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407152101 · Cited by 297 · cited 1×
“The missing loops in the crystal structures were built using libraries of backbone fragments (55) or by constraint space de novo reconstruction of these backbone segments (56).”
BackgroundA nicotinic hypothesis for Covid-19 with preventive and therapeutic implications
Changeux, J.-P., Amoura, Z., Rey, F. A., & Miyara, M. (2020) · Comptes Rendus. Biologies · doi:10.5802/crbiol.8 · Cited by 289
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.29.174888 · Cited by 272
Superantigens: Bacterial and Viral Proteins that Manipulate the Immune System
Scherer, M. T., Ignatowicz, L., Winslow, G. M., Kappler, J. W., & Marrack, P. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.000533 · Cited by 238
Belhadjer, Z., Méot, M., Bajolle, F., Khraiche, D., Legendre, A., Abakka, S., Auriau, J., Grimaud, M., Oualha, M., Beghetti, M., et al. (2021) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/j.acvdsp.2021.06.005 · Cited by 209
Will children reveal their secret? The coronavirus dilemma
Cristiani, L., Mancino, E., Matera, L., Nenna, R., Pierangeli, A., Scagnolari, C., & Midulla, F. (2020) · European Respiratory Journal · doi:10.1183/13993003.00749-2020 · Cited by 200
Automated Protein Structure Modeling with SWISS-MODEL Workspace and the Protein Model Portal
Bordoli, L., & Schwede, T. F. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-588-6_5 · Cited by 166
Will children reveal their secret? The coronavirus dilemma
Midulla, F., Cristiani, L., & Mancino, E. (2020) · European Respiratory Journal · doi:10.1183/13993003.01617-2020 · Cited by 160
Arad, G., Levy, R., Nasie, I., Hillman, D., Rotfogel, Z., Barash, U., Supper, E., Shpilka, T., Minis, A., & Kaempfer, R. O. R. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001149 · Cited by 153
Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock
Krakauer, T. (2019) · Toxins · doi:10.3390/toxins11030178 · Cited by 131
Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2
Renn, A., Fu, Y., Hu, X., Hall, M. D., & Simeonov, A. M. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.07.004 · Cited by 121
Low, D. E. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.03.012 · Cited by 106
Saline, M., Rödström, K. E. J., Fischer, G. W., Orekhov, V., Karlsson, G., & Lindkvist‐Petersson, K. (2010) · Nature Communications · doi:10.1038/ncomms1117 · Cited by 75
Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin B
Larkin, E. A., Stiles, B. G., & Ulrich, R. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013253 · Cited by 66
Simnica, D., Akyüz, N., Schliffke, S., Mohme, M., von Wenserski, L., Mährle, T., Fanchi, L. F., Lamszus, K., & Binder, M. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1644110 · Cited by 63
Self-citationPerspectives on the development of neutralizing antibodies against SARS-CoV-2
Ho, M. (2020) · Antibody Therapeutics · doi:10.1093/abt/tbaa009 · Cited by 49
Krakauer, T., Buckley, M. J., Issaq, H. J., & Fox, S. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01015-09 · Cited by 45
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implicationsPreprint
Changeux, J., Amoura, Z., Rey, F. A., & Miyara, M. (2020) · doi:10.32388/fxgqsb · Cited by 45
SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence?Preprint
Zhan, S. H., Deverman, B. E., & Chan, Y. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.01.073262 · Cited by 45
Dutta, K., Varshney, A. K., Franklin, M. C., Goger, M. J., Wang, X., & Fries, B. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.630715 · Cited by 41
Popugailo, A., Rotfogel, Z., Supper, E., Hillman, D., & Kaempfer, R. O. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00942 · Cited by 33
Bracci, L., Ballas, S. K., Spreafico, A., & Neri, P. (1997) · Blood · doi:10.1182/blood.v90.9.3623 · Cited by 30
Simnica, D., Schliffke, S., Schultheiß, C., Bonzanni, N., Fanchi, L. F., Akyüz, N., Gösch, B., Casar, C., Thiele, B., Schlüter, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01897 · Cited by 29
Self-citationWhitfield, S. J., Taylor, C., Risdall, J. E., Griffiths, G. D., Jones, J. T. A., Williamson, E. D., Rijpkema, S. G. T., Saraiva, L., Vessillier, S., Green, A. C., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601525 · Cited by 21
Superantigens: Bacterial and Viral Proteins that Manipulate the Immune System
Scherer, M. T. (1993) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.9.1.101 · Cited by 14
Cited by
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., Bonanomi, E., & D'Antiga, L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31103-x · Cited by 2,380
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Jiang, L., Tang, K., Levin, M., Irfan, O., Morris, S. K., Wilson, K., Klein, J. D., & Bhutta, Z. A. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30651-4 · Cited by 826
Swank, Z., Senussi, Y., Manickas-Hill, Z., Yu, X. G., Li, J. Z., Alter, G., & Walt, D. R. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac722 · Cited by 572
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2
Nguyen, A., David, J. K., Maden, S. K., Wood, M. A., Weeder, B. R., Nellore, A., & Thompson, R. F. (2020) · Journal of Virology · doi:10.1128/jvi.00510-20 · Cited by 561
Weisberg, S. P., Connors, T. J., Zhu, Y., Baldwin, M. R., Lin, W.-H., Wontakal, S., Szabo, P. A., Wells, S. B., Dogra, P., Gray, J., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00826-9 · Cited by 548
Metadata
- Authors
- Cheng, M. H., Zhang, S., Porritt, R. A., Noval Rivas, M., Paschold, L., Willscher, E., Binder, M., Arditi, M., & Bahar, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2020-09-28
- Volume
- 117
- Issue
- 41
- Pages
- 25254-25262
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W3088054800
- Cited by
- 393
- References
- 64
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.